EvoEndo, Inc. is a medical technology company based in Denver, Colorado, that specializes in sedation-free transnasal endoscopy (TNE). The company provides specialized medical devices and pediatric-friendly procedures for gastrointestinal examinations. EvoEndo's products are designed for use by trained physicians to perform unsedated endoscopies.
Subscribe to see EvoEndo, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EvoEndo, Inc. is a medical devices company headquartered in United States. It has raised at least $12.1M across the 2 funding rounds on record. Its most recent funding round raised $2.3M in August 2024. Xcout tracks 14 named people at EvoEndo, Inc., including Jonathan T. Hartmann (Chief Executive Officer).
8 more named people on record for EvoEndo, Inc., with roles, board committees and tenure — see the full roster →
At least $12.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.3M | — | |
| Series A | $9.8M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of EvoEndo, Inc.'s closest competitors — see the full list of competitors and alternatives →
Neptune Medical is a privately held medical-device company that develops minimally invasive tools, particularly for gastrointestinal endoscopy and other interventional procedures. Its products are intended for physicians and healthcare providers to improve the navigation, access, and delivery of care during procedures.
EnteroTrack, LLC provides the Esophageal String Test (EST) using its EnteroTracker device, offering a minimally invasive, non-endoscopic tool for clinicians to collect upper gastrointestinal samples and monitor Eosinophilic Esophagitis (EoE) activity in patients. The office-based procedure helps assess mucosal inflammation and biomarkers over time, potentially reducing the need for repeated endoscopies.
Motus GI Holdings, Inc. is a U.S. medical-device company that developed the Pure-Vu System, designed to improve colon cleansing and visualization during colonoscopy. Its products serve gastroenterologists, hospitals, and other healthcare providers performing lower gastrointestinal endoscopic procedures.
ColoWrap is a medical device company headquartered in Chapel Hill, North Carolina, focused on creating zero-harm endoscopy environments. The company developed the ColoWrap Anti-Looping Abdominal Compression Device to shorten colonoscopy procedure times.
Endoquest Robotics develops a flexible robotic surgery system designed to enable minimally invasive endoluminal and single-incision surgeries through natural orifices or transumbilical incisions. The system aims to eliminate or minimize external incisions, reduce patient trauma, and enhance physician capabilities. Their technology is currently under development and not yet cleared for commercial sale.
Peytant Solutions, Inc. is a privately held medical technology company headquartered in Minneapolis, Minnesota, focused on transforming the treatment of luminal diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.